{"name":"Steven Deeks","slug":"steven-deeks","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"INO-9012","genericName":"INO-9012","slug":"ino-9012","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"INO-9012","genericName":"INO-9012","slug":"ino-9012","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxPdlFUbmZSakxjcHFqSHBLblhJLVBoZGxaSjZJUGFnQy1QMXBXRDNHaWdQdWpxYVVVaHkxMHNoSmlZNW9ZRm5Ec2J6TFlLV3dnM3hWYklpWnJNRXkwejYzb19ObHBrNHJDc0tsUVR6U29weGxWS1BUQ3BSVW5velFqV2ZxZ2djb3JfNUdjQUs0WDJlNHdWZ1ZpV0J0WWJOQ0JFWFdDOVM2Rm5FSVpTYkR4aGJPY2lQdURzY1lLRjVUbjFGbEhoZVNaaWNQU0RVR3hKZ25RT251Yy0?oc=5","date":"2025-12-01","type":"pipeline","source":"News-Medical","summary":"Combination immunotherapy may be the key to control HIV without long-term antiviral treatment - News-Medical","headline":"Combination immunotherapy may be the key to control HIV without long-term antiviral treatment - News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFBPMlNvLTRLYjVrMTdkdURyMzhkcGU3S3N2amY2NVdQRkNzRjRFWUpWbVVSczBlVHo3ZkpVZjFCbkFyd2JjbkgtTWhJdUc0V0xZR0c2MHNvNmhSYXo5X3VQMVJ6czRCSklvUC1nbEZqSjFVbWdvYXh3?oc=5","date":"2025-12-01","type":"trial","source":"The Washington Post","summary":"Small study shows a promising path toward HIV cure - The Washington Post","headline":"Small study shows a promising path toward HIV cure","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPVnRobEhLMTQ4a0pZVEgwQzhCN1RWQUZLazFhSnRGbUZqUlUzMm1LdDdSVjVyVGRKODZtZUxNRDRNcTRtX1FQQzR3ejRqdU9uaktTUWtkU3o3bGVPTFB1Q2lRckdWRDg0ck1zdlFIbmUzUXoyS0RDSnBROHpGbnA1THk4RFB0eDliTmhTd083NlJvaHQ3WUtfZHROV2hyd0xTRzJrXzQ0MXdRRmd1VXlhcnZoekpiYl9oSl93?oc=5","date":"2023-02-03","type":"pipeline","source":"Pharmaceutical Technology","summary":"HIV vaccines suffer setbacks but new approaches could turn the tide - Pharmaceutical Technology","headline":"HIV vaccines suffer setbacks but new approaches could turn the tide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPUXNMYVZiZHNHYUxkbzBRZWtOOEhJVUlMY1BVRVRXZHRJVV9Ed2hHc05lMHp3d3pxdHVuLXpNbG16bi1ydlpTWHlKRUd5aUdnUXlZUnFiZnpBRVJOcE5KTWFOLWUtM05mWExLcG9KckV2Z1RVRVBGM29jZzllNXhIaGpWb0ZvZw?oc=5","date":"2022-12-02","type":"trial","source":"KFF Health News","summary":"The Business of Clinical Trials Is Booming. Private Equity Has Taken Notice. - KFF Health News","headline":"The Business of Clinical Trials Is Booming. Private Equity Has Taken Notice.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE56b1BrNE9iOVMydVlaSmx1S0ptdUNGU0ZBVENGMFQ4NWpnc20xcThLWFl1WktULVMzNjhQU09VOG02cTdsWWxERDR0SHdEazJPcnRRZw?oc=5","date":"2022-06-27","type":"pipeline","source":"poz.com","summary":"Searching for a Cure - poz.com","headline":"Searching for a Cure","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQZFpERE5wck1DMUZZV0MzeHhGRkhNdHZxbVUxZDR2QlY0ZEhtMGstRXhPaVA1QXljQmVaQ01rY2UzRGNvLTA4MlZ3MW02cEd3SXdhLWFfT21Mcm1ZbWJaRDZpWVZVS1o5Z3dCcVl1VFFCYTB3OUJYS19UcVlYblVqNF9mc2xJbGlkclcxTE40Z2NzU1V2U0Z5emVqaWJ5SndiQWFlWHBFbUxrOEI3SGo1Q0ZycjJXUXBPT0RoSVVn?oc=5","date":"2022-04-18","type":"pipeline","source":"Reuters","summary":"The case for testing Pfizer's Paxlovid for treating long COVID - Reuters","headline":"The case for testing Pfizer's Paxlovid for treating long COVID","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}